Streetbeat News

Price Targets

SMG

Stifel analyst W. Andrew Carter maintains a Hold rating on Scotts Miracle Gro (SMG) and raises the price target from $49 to $55 as of 4 February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 9:23 pm

SMG

Stifel analyst W. Andrew Carter maintains a Hold rating on Scotts Miracle Gro (SMG) and raises the price target from $49 to $55.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 9:22 pm

TNDM

Stifel analyst Rick Wise maintains a Hold rating on Tandem Diabetes Care (TNDM) and raises the price target from $17 to $24.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 9:19 pm

POST

Stifel analyst Matthew Smith maintains a Buy rating on Post Holdings (NYSE:POST) and raises the price target from $98 to $115 as of 4 February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 9:16 pm

NOV

Stifel analyst Stephen Gengaro maintains a Buy rating on NOV Inc. (NYSE:NOV) but lowers the price target from $28 to $26 as of 4 February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 9:13 pm

PODD

Stifel analyst Mathew Blackman has maintained a Hold rating on Insulet (NASDAQ:PODD) and increased the price target from $163 to $208. This adjustment reflects a more optimistic outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 9:11 pm

EMN

Stifel analyst Vincent Anderson maintains a Buy rating on Eastman Chemical (NYSE:EMN) but lowers the price target from $102 to $101 as of 2 February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 9:09 pm

DLR

Stifel analyst Erik Rasmussen maintains a Buy rating on Digital Realty Trust (DLR) and raises the price target from $145 to $155.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 9:08 pm

CLB

Stifel analyst Stephen Gengaro maintains a Hold rating on Core Laboratories (NYSE:CLB) and lowers the price target from $21 to $17 as of 4 February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 9:06 pm

HASI

In the last three months, Hannon Armstrong (NYSE:HASI) received diverse analyst ratings, with a recent shift towards a more bullish outlook. The average 12-month price target was adjusted to $32.00 from $33.00, reflecting a slight decline in expectations. Analysts from B. Riley Securities, Mizuho, and Goldman Sachs have updated their ratings and price targets, indicating varying levels of optimism about the company's future performance. Hannon Armstrong, focusing on financing energy-efficiency and renewable-energy projects, shows strong market recognition but faces challenges in revenue growth and maintains a solid net margin and ROE.

Portfolio Pulse from Benzinga Insights

February 05, 2024 | 9:00 pm